NCT03132636 2025-04-08PD-1 in Patients With Advanced Basal Cell Carcinoma Who Experienced Progression of Disease on Hedgehog Pathway Inhibitor Therapy, or Were Intolerant of Prior Hedgehog Pathway Inhibitor TherapyRegeneron PharmaceuticalsPhase 2 Completed138 enrolled 21 charts 1 FDA